Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study

American Heart Journal

Volumn 165, Issue 1, 2013, Pages

  Turakhia, Mintu P ^a,b   Hoang, Donald D ^a   Xu, Xiangyan ^a   Frayne, Susan ^a,b   Schmitt, Susan ^a   Yang, Felix ^a   Phibbs, Ciaran S ^a,b   Than, Claire T ^a   Wang, Paul J ^b   Heidenreich, Paul A ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; CARDIOLOGY; CEREBROVASCULAR ACCIDENT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84870925736     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.10.010     Document Type: Article

References (41)

1. W.M. Feinberg, J.L. Blackshear, and A. Laupacis Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 5 1995 469 473
2. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 18 2001 2370 2375
3. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study Arch Intern Med 147 9 1987 1561 1564
4. B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 22 2001 2864 2870
5. A.J. Camm, P. Kirchhof, and G.Y.H. Lip Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2010 2369 2429
6. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 7 2006 e257 e354
7. D. Singer, G. Albers, and J. Dalen Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl 2008 546S 592S
8. D. Singer, G. Albers, and J. Dalen Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 429S 456S
9. V. Snow, K.B. Weiss, and M. LeFevre Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians Ann Intern Med 139 12 2003 1009 1017
10. D.C. Cowper, D.M. Hynes, and J.D. Kubal Using administrative databases for outcomes research: select examples from VA Health Services Research and Development J Med Syst 23 3 1999 249 259
11. M.W. Smith, and G.J. Joseph Pharmacy data in the VA health care system Med Care Res Rev 60 3 Suppl 2003 92S 123S
12. Tarlov E. Applying comorbidity measure using VA and Medicare data. In: 2011 VIReC Database and Methods Cyber Seminar Series; 2011: VA Information Resource Center; 2011.
13. H. Quan, V. Sundararajan, and P. Halfon Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 43 11 2005 1130 1139
14. A. Selim, G. Fincke, and X. Ren The comorbidity index in measuring and managing health care quality 2002 Aspen Publishers Gaithersburg, MD
15. S.M. Frayne, J.H. Halanych, and D.R. Miller Disparities in diabetes care: impact of mental illness Arch Intern Med 165 22 2005 2631 2638
16. J.H. Halanych, F. Wang, and D.R. Miller Racial/ethnic differences in diabetes care for older veterans: accounting for dual health system use changes conclusions Medical care 44 5 2006 439 445
17. A.M. Borzecki, A.T. Wong, and E.C. Hickey Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? Am J Med Qual 19 5 2004 201 206
18. M.C. Fang, A.S. Go, and Y. Chang A new risk scheme to predict warfarin-associated hemorrhage the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study J Am Coll Cardiol 58 4 2011 395 401
19. S.M. Wright, J. Daley, and E.S. Fisher Where do elderly veterans obtain care for acute myocardial infarction: Department of Veterans Affairs or Medicare? Health Serv Res 31 6 1997 739 754
20. D.M. Hynes, K. Koelling, and K. Stroupe Veterans' access to and use of Medicare and Veterans Affairs health care Med Care 45 3 2007 214 223
21. VIReC. VIReC research user guide:1999-2006 VHA Assistant Deputy Under Secretary for Health (ADUSH) Monthly Enrollment File. In. Hines: VA Information Resource Center; 2006. p. 145.
22. N.L. Glazer, S. Dublin, and N.L. Smith Newly detected atrial fibrillation and compliance with antithrombotic guidelines Arch Intern Med 167 3 2007 246 252
23. M.R. Reynolds, J. Shah, and V. Essebag Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry Am J Cardiol 97 4 2006 538 543
24. T. Darkow, A.M. Vanderplas, and K.H. Lew Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system Curr Med Res Opin 21 10 2005 1583 1594
25. G. Breithardt, D. Dobrev, and N. Doll The German Competence Network on Atrial Fibrillation (AFNET) Herz 33 8 2008 548 555
26. T. Dinh, R. Nieuwlaat, and R.G. Tieleman Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in the Netherlands-the EXAMINE-AF study. A questionnaire survey Int J Clin Pract 61 1 2007 24 31
27. R. Nieuwlaat, A. Capucci, and G.Y. Lip Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 24 2006 3018 3026
28. G.Y. Lip, J.L. Halperin, and H.F. Tse The 2010 European Society of Cardiology guidelines on the management of atrial fibrillation: an evolution or revolution? Chest 139 4 2011 738 741
29. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 2009 1139 1151
30. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 11 2011 981 992
31. D.R. Holmes, V.Y. Reddy, and Z.G. Turi Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 9689 2009 534 542
32. D.A. Redelmeier, S.H. Tan, and G.L. Booth The treatment of unrelated disorders in patients with chronic medical diseases N Engl J Med 338 21 1998 1516 1520
33. G.H. Guyatt, E.A. Akl, and M. Crowther Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2 suppl 2012 7S 47S
34. P. Heidenreich Improving heart failure care with a reminder attached to the echocardiography report Am J Med 121 10 2008 853 854
35. P.A. Heidenreich, M. Chacko, M.K. Goldstein, and J.E. Atwood ACE inhibitor reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction Am J Med 118 9 2005 1034 1037
36. P.A. Heidenreich, P. Gholami, and A. Sahay Clinical reminders attached to echocardiography reports of patients with reduced left ventricular ejection fraction increase use of β-blockers Circulation 115 22 2007 2829 2834
37. Gupta A, Gholami P, Turakhia M, et al. Clinical reminders to providers of patients with depressed left ventricular ejection fraction increase defibrillator implantation: a randomized trial. Accepted for oral presentation at 2011 American Heart Association Scientific Sessions 2011.
38. G.C. Fonarow, N.M. Albert, and A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 6 2010 585 596
39. Ezekowitz MD, Connolly S, Parekh A, et al. Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran. Am Heart J 2009;157(5):805-10, 810 e1-2.
40. J.V. Freeman, R.P. Zhu, and D.K. Owens Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation Ann Intern Med 154 1 2011 1 11
41. D.B. Matchar, A. Jacobson, and R. Dolor Effect of home testing of international normalized ratio on clinical events N Engl J Med 363 17 2010 1608 1620